Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribonuclease A family member 8 (RNASE8) is an enzyme belonging to the ribonuclease A superfamily, specifically the pancreatic ribonuclease family. It was first identified as being uniquely expressed in the placenta, but later evidence suggests additional expression in lung, liver, and testes[1][4]. RNASE8 shows unusually low ribonucleolytic activity, and currently available data do not demonstrate classic antimicrobial, antibacterial, or antiviral activity typical of some other RNase A family members[1][4]. The gene exhibits an accelerated rate of evolution and has accumulated unique sequence features, such as distinctive disulfide bonding and an extended N-terminus, which could reflect specialized or diverged physiological roles compared to other family members[1][4]. Its closest homolog is RNASE7, and both genes appear to have arisen from a recent duplication event in primate evolution[1]. There is no evidence that RNASE8 is a therapeutic target in current clinical or pharmacological contexts[1][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribonuclease A family member 8 (RNASE8).